Health

AI scheduler for care staff ‘could tackle discharge delays and waiting lists’




Data from a pilot showed the platform boosted care visits by more than a third.



READ SOURCE

Read More   Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rival

This website uses cookies. By continuing to use this site, you accept our use of cookies.